Literature DB >> 11370803

Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.

H W Rhee1, H E Zhau, S Pathak, A S Multani, S Pennanen, T Visakorpi, L W Chung.   

Abstract

A three-dimensional (3D) integrated rotating-wall vessel cell-culture system was used to evaluate the interaction between a human prostate cancer cell line, LNCaP, and microcarrier beads alone, or microcarrier beads previously seeded with either prostate or bone stromal cells. Upon coculture of LNCaP cells with microcarrier beads either in the presence or in the absence of prostate or bone stromal cells, 3D prostate organoids were formed with the expected hormonal responsiveness to androgen, increased cell growth, and prostate-specific antigen production. In this communication, we define permanent phenotypic and genotypic changes of LNCaP cells upon coculture with microcarrier beads alone, or with microcarrier beads previously seeded with either prostate or bone stromal cells. Most notably, we observed selective genetic changes, i.e., chromosomal losses or gains, as evaluated by both conventional cytogenetic and comparative genomic hybridization, in LNCaP sublines derived from the prostate organoids. Moreover, the derivative LNCaP cells appear to have altered growth profiles, and exhibit permanent and stable changes in response to androgen, estrogen, and growth factors. The derivative LNCaP sublines showed increased anchorage-independent growth rate, and enhanced tumorigenicity and metastatic potential when inoculated orthotopically in castrated athymic mice. Our results support the hypothesis that further nonrandom genetic and phenotypic changes in prostate cancer epithelial cells can occur through an event that resembles "adaptive mutation" such as has been described in bacteria subjected to nutritional starvation. The occurrence of such permanent changes may be highly contact dependent, and appears to be driven by specific microenvironmental factors surrounding the tumor cell epithelium grown as 3D prostate organoids.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11370803     DOI: 10.1290/1071-2690(2001)037<0127:PPAGCO>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.723


  37 in total

1.  The experimental study of tumor progression: a review.

Authors:  L FOULDS
Journal:  Cancer Res       Date:  1954-06       Impact factor: 12.701

2.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Authors:  M Gibbs; J L Stanford; R A McIndoe; G P Jarvik; S Kolb; E L Goode; L Chakrabarti; E F Schuster; V A Buckley; E L Miller; S Brandzel; S Li; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

3.  Effects of simulated microgravity on DU 145 human prostate carcinoma cells.

Authors:  S Clejan; K C O'Connor; N L Cowger; M K Cheles; S Haque; A C Primavera
Journal:  Biotechnol Bioeng       Date:  1996-06-05       Impact factor: 4.530

4.  Simulated microgravity conditions enhance differentiation of cultured PC12 cells towards the neuroendocrine phenotype.

Authors:  P I Lelkes; D L Galvan; G T Hayman; T J Goodwin; D Y Chatman; S Cherian; R M Garcia; B R Unsworth
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-04       Impact factor: 2.416

5.  Cytogenetic, morphologic and oncogene analysis of a cell line derived from a heterologous mixed mullerian tumor of the ovary.

Authors:  J L Becker; P R Papenhausen; R H Widen
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-05       Impact factor: 2.416

6.  Culture of a prostatic cell line in basement membrane gels results in an enhancement of malignant properties and constitutive alterations in gene expression.

Authors:  M R Freeman; D J Bagli; C C Lamb; P D Guthrie; T Uchida; R E Slavin; L W Chung
Journal:  J Cell Physiol       Date:  1994-02       Impact factor: 6.384

7.  LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis.

Authors:  G N Thalmann; R A Sikes; T T Wu; A Degeorges; S M Chang; M Ozen; S Pathak; L W Chung
Journal:  Prostate       Date:  2000-07-01       Impact factor: 4.104

8.  Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.

Authors:  S S Padalecki; D A Troyer; M F Hansen; T Saric; B G Schneider; P O'Connell; R J Leach
Journal:  Int J Cancer       Date:  2000-03-01       Impact factor: 7.396

9.  Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers.

Authors:  J T Isaacs; W B Isaacs; W F Feitz; J Scheres
Journal:  Prostate       Date:  1986       Impact factor: 4.104

10.  The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.

Authors:  R L Noble
Journal:  Cancer Res       Date:  1977-06       Impact factor: 12.701

View more
  28 in total

Review 1.  Advances in preclinical investigation of prostate cancer gene therapy.

Authors:  Marxa L Figueiredo; Chinghai Kao; Lily Wu
Journal:  Mol Ther       Date:  2007-04-24       Impact factor: 11.454

2.  Reef-coral proteins as visual, non-destructive reporters for plant transformation.

Authors:  A Wenck; C Pugieux; M Turner; M Dunn; C Stacy; A Tiozzo; E Dunder; E van Grinsven; R Khan; M Sigareva; W C Wang; J Reed; P Drayton; D Oliver; H Trafford; G Legris; H Rushton; S Tayab; K Launis; Y-F Chang; D-F Chen; L Melchers
Journal:  Plant Cell Rep       Date:  2003-08-27       Impact factor: 4.570

3.  Cancer-stromal cell fusion as revealed by fluorescence protein tracking.

Authors:  Ruoxiang Wang; Michael S Lewis; Ji Lyu; Haiyen E Zhau; Stephen J Pandol; Leland W K Chung
Journal:  Prostate       Date:  2019-12-17       Impact factor: 4.104

4.  Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue.

Authors:  Pavinder Kaur; Brenda Ward; Baisakhi Saha; Lillian Young; Susan Groshen; Geza Techy; Yani Lu; Roscoe Atkinson; Clive R Taylor; Marylou Ingram; S Ashraf Imam
Journal:  J Histochem Cytochem       Date:  2011-10-27       Impact factor: 2.479

5.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

6.  Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells.

Authors:  Xiaojuan Sun; Hui He; Zhihui Xie; Weiping Qian; Haiyen E Zhau; Leland W K Chung; Fray F Marshall; Ruoxiang Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-04-10       Impact factor: 2.416

Review 7.  Tumor-stroma co-evolution in prostate cancer progression and metastasis.

Authors:  Sajni Josson; Yasuhiro Matsuoka; Leland W K Chung; Haiyen E Zhau; Ruoxiang Wang
Journal:  Semin Cell Dev Biol       Date:  2009-12-03       Impact factor: 7.727

8.  Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

Authors:  Shian-Ying Sung; Chia-Ling Hsieh; Andrew Law; Haiyen E Zhau; Sen Pathak; Asha S Multani; Sharon Lim; Ilsa M Coleman; Li-Chin Wu; William D Figg; William L Dahut; Peter Nelson; Jae K Lee; Mahul B Amin; Robert Lyles; Peter A J Johnstone; Fray F Marshall; Leland W K Chung
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

9.  An efficient mannose selection protocol for tomato that has no adverse effect on the ploidy level of transgenic plants.

Authors:  Marina Sigareva; Rody Spivey; Michael G Willits; Catherine M Kramer; Yin-Fu Chang
Journal:  Plant Cell Rep       Date:  2004-06-09       Impact factor: 4.570

Review 10.  Biomechanical forces in the skeleton and their relevance to bone metastasis: biology and engineering considerations.

Authors:  Maureen E Lynch; Claudia Fischbach
Journal:  Adv Drug Deliv Rev       Date:  2014-08-29       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.